Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $21.46 USD
Change Today +0.05 / 0.23%
Volume 126.4K
ATRC On Other Exchanges
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

atricure inc (ATRC) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/25/15 - $22.97
52 Week Low
10/8/14 - $13.19
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ATRICURE INC (ATRC)

Related News

No related news articles were found.

atricure inc (ATRC) Related Businessweek News

No Related Businessweek News Found

atricure inc (ATRC) Details

AtriCure, Inc., a medical device company, provides atrial fibrillation solutions worldwide. The company offers Isolator Synergy ablation system and related radio frequency(RF) ablation devices, which include clamps that are used for ablation during open-heart procedures; ablation and sensing unit, a compact power generator that delivers bipolar RF energy to its clamps, multifunctional pens, and Coolrail linear ablation devices; AtriCure Switch Box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in clamps; and Coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. It also provides Isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias; perform temporary cardiac pacing, sensing, and stimulation; and ablate cardiac tissue with the same device. In addition, the company provides Fusion surgical ablation system; Estech electrosurgical unit, a compact power generator for use with Fusion ablation products; AFfirm bipolar pacing probes used to test lesions created in surgically treating the patient’s arrhythmia; cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; and AtriClip system that is designed for the left atrial appendage management. Further, it sells enabling technologies, including Lumitip dissector to separate tissues to provide access to anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments that are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products to hospitals and medical centers through independent distributors and direct sales personnel. AtriCure, Inc. is headquartered in West Chester, Ohio.

320 Employees
Last Reported Date: 03/2/15

atricure inc (ATRC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $515.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $265.6K
Chief Operating Officer
Total Annual Compensation: $324.0K
Senior Vice President of Operations & Quality...
Total Annual Compensation: $286.4K
Vice President and General Manager of Interna...
Total Annual Compensation: $272.4K
Compensation as of Fiscal Year 2014.

atricure inc (ATRC) Key Developments

AtriCure, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 03:00 PM

AtriCure, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 03:00 PM. Venue: Westin Grand Central Hotel, New York, New York, United States.

AtriCure Launches Cryo Ablation Solution for Treatment of Post-Thoracotomy Pain

AtriCure announced that it has launched its cryoICE cryo ablation probe to provide temporary pain management associated with a thoracotomy. CryoICE is the first Food and Drug Administration-cleared cryo ablation probe for the treatment of cardiac arrhythmias and for the temporary ablation of peripheral nerves to block pain. Cryoanalgesia is a method of temporarily relieving pain by cryo ablating the affected nerve, causing an interruption of pain impulses to the brain.

AtriCure, Inc. - Analyst/Investor Day

To discuss strategy for executing on its growth initiatives as well as to provide clinical perspective


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRC:US $21.46 USD +0.05

ATRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CryoLife Inc $9.91 USD -0.34
Cutera Inc $13.97 USD +0.04
Sequenom Inc $4.28 USD -0.06
STAAR Surgical Co $9.10 USD -0.27
SurModics Inc $26.34 USD -0.58
View Industry Companies

Industry Analysis


Industry Average

Valuation ATRC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.4x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATRICURE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at